Treating Hypertension in Children With N-Of-1 Trials

Pediatrics - United States
doi 10.1542/peds.2018-1818
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Academy of Pediatrics (AAP)

Related search

N-Of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

Journal of General Internal Medicine
Internal Medicine
2019English

Ethics in N-Of-1 Trials

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Reviving the Use of Aldosterone Inhibitors in Treating Hypertension in Obesity: Fig. 1.

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2015English

Can Nesfatin-1 Predict Hypertension in Obese Children?

JCRPE Journal of Clinical Research in Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2020English

Endothelin-1 (ET-1), N-Terminal Fragment of Pro-Atrial Natriuretic Peptide (NTpro-ANP), and Tumour Necrosis Factor Alpha (TNF-α) in Children With Primary Hypertension and Hypertension of Renal Origin

Endokrynologia Polska
EndocrinologyMetabolismDiabetes
2019English

Treating Hypertension in the Very Old

New England Journal of Medicine
Medicine
2008English

Behavioral and Cognitive Outcomes for Clinical Trials in Children With Neurofibromatosis Type 1

Neurology
Neurology
2015English

N-Of-1 Trials of Expensive Biological TherapiesA Third Way?

Archives of Internal Medicine
2008English

Pcv15 - Drugs for Treating Severe Hypertension in Pregnancy: A Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy